Clinical Trial Update: Lucentis (Ranibizumab) for Eales' Disease [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on Ranibizumab (Lucentis) for Eales' Disease with Phase 2 and Phase 3 completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eales Disease

Drugs mentioned

• Lucentis (ranibizumab)

Snippet

Sponsor: Oregon Health and Science University | Conditions: Eales' Disease | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2019-06-11